Matsuda Yukihiro, Tsuda Hiroshi, Takasaki Yoshinari, Hashimoto Hiroshi
Division of Rheumatology, Chiba Social Insurance Hospital, Chiba, Japan.
Ther Apher Dial. 2004 Oct;8(5):404-8. doi: 10.1111/j.1526-0968.2004.00173.x.
A 68-year-old-male who was diagnosed as having rheumatoid arthritis (RA) 7 years previously was admitted the Chiba Social Insurance Hospital due to general fatigue, spiking fever, and appetite loss. Blood tests showed extremely high levels of C-reactive protein (CRP, 318.5 mg/dL), and hypergammapathy (IgG 3228 mg/dL, IgA 905 mg/dL, IgM 2537 mg/dL) and high titers of rheumatoid factor (RAPA 40960X). He was diagnosed as having RA with vasculitis, according to interstitial pneumonitis, cutaneous nodules and polyneuropathy. Prednisolone (30 mg/day) was prescribed, however, myeloperoxidase-antineutrophil cytoplasmic antibody proved to be positive (86EU) and cyclophosphamide (50 mg/day) was added one week later. Additionally, IgM K-chain M-protein was revealed and the differentiation between auto-immune and hematologic diseases was required for further drug prescriptions. Therefore, double filtration plasmapheresis (DFPP) was initiated weekly. Hematologic diseases were negated and the hypergammapathy was improved. C-reactive protein and MPO-ANCA decreased to the normal level after three sessions (IgG 1064 mg/dL, IgA 331 mg/dL, IgM 94 mg/dL, CRP 0.04 mg/dL) and the patients symptoms improved. Prednisolone was tapered and he was discharged. It was suggested that the case presented here was quite rare, having an extremely high level of CRP which was successfully managed by DFPP.
一名68岁男性,7年前被诊断为类风湿性关节炎(RA),因全身乏力、高热和食欲减退入住千叶社会保险医院。血液检查显示C反应蛋白(CRP)水平极高(318.5mg/dL),存在高丙种球蛋白血症(IgG 3228mg/dL,IgA 905mg/dL,IgM 2537mg/dL)以及高滴度类风湿因子(RAPA 40960X)。根据间质性肺炎、皮肤结节和多发性神经病,他被诊断为患有血管炎的RA。给予泼尼松龙(30mg/天)治疗,然而,髓过氧化物酶抗中性粒细胞胞浆抗体检测呈阳性(86EU),一周后加用环磷酰胺(50mg/天)。此外,发现了IgM K链M蛋白,为进一步用药需要区分自身免疫性疾病和血液系统疾病。因此,开始每周进行一次双重过滤血浆置换(DFPP)。排除了血液系统疾病,高丙种球蛋白血症得到改善。三次治疗后C反应蛋白和MPO-ANCA降至正常水平(IgG 1064mg/dL,IgA 331mg/dL,IgM 94mg/dL,CRP 0.04mg/dL),患者症状改善。泼尼松龙逐渐减量,患者出院。提示本文所述病例非常罕见,CRP水平极高,通过DFPP成功治疗。